🔥Telegram İfşa

If you are near Marseille October 3-5, come and support the #OranoMed crew in the Neptunium 2019 sailing race. Good luck to our team!

Orano Med increases its capacity for the production of Lead-212 for the development of cancer treatments. bit.ly/38AUS09

HIRING: Join our team! We are seeking a Senior Manager, QA/QC in Plano, TX. See Indeed for details and application: indeedhi.re/3kZ2Fr2

Join our Chief Medical Officer, Jason D. Hurt, MD, at the Targeted Radiopharmaceuticals 2020 Summit as he discusses conducting clinical oncology trials with radiopharmaceuticals. #radiopharma #oncology

HIRING: Join our team! We are seeking a Head of Production Unit in Brownsburg, IN. See details and application: bit.ly/39ufruN

Interesting joint paper by @FORATOM_nuclear and Nuclear Medicine Europe. Nuclear has an important role to play in medicine: Orano Group, through its subsidiary Orano Med, is committed to accelerate development of therapies and to supply treatment against cancer #CancerResearch

📸Orano Med est fier d'inaugurer à Bessines (87), l’extension du Labo. M. Tubiana & son Centre #RetD dédié à la fabrication du #Plomb212, élément radioactif rare utilisé pr le dév. de traitements innovants contre le #cancer. 🔬 Cc. Pascale Rodrigo; Andréa Brouille; Claude Imauven

Orano Med is proud to inaugurate extension of the Maurice Tubiana Laboratory and its new Research & Development Center in Bessines-France, for the manufacturing of Lead-212 #Plomb212, used for the development of Targeted Alpha Thérapies against #cancer.

Proud of the important steps taken by Orano Med! orano.group/en/news/news-g…

We are hiring in the US! - Executive assistant - Purchasing agent - HR generalist - Laboratory instrument repair/calibration - QA specialist - QC analyst - Manufacturing technician - Head of regulatory affairs - IS/IT/Helpdesk Send your resume to [email protected].

[PR] Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers 👉cutt.ly/jeRbvOFO

🚀 Exciting news! #OranoMed has signed an exclusive licensing agreement with Sanofi for the commercialization of our most advanced treatment, AlphaMedix™, developed with RadioMedix, Inc.. A major step toward bringing this therapy to patients worldwide! 🌍 ➡️ oranomed.com/en/resources/n…

From Zurich: The CEO of Orano Med gives an overview of the radiopharmaceutical approach and why he believes alpha emitters are the way to go. Full video: biotechtv.com/post/orano-med…

Ready to talk about careers in nuclear medicine production and delivery in the fight against cancer? Our Orano Med team is recruiting at Purdue University today! #OranoHires @purduewin @purduenuclear Purdue ANS opp.purdue.edu/events/2024/pu…

[CP] Sanofi et Orano Med unissent leurs forces pour développer des #radiothérapies internes vectorisées de nouvelle génération 👉 bit.ly/3Nspu7h

Nous sommes ravis d’annoncer la #signature d’un accord d’investissement de @Sanofi dans nos activités de biotechnologies, avec une participation de 16% environ pour 300 millions d’euros. 🎉   Pour en savoir plus 👉 oranomed.com/fr/ressources/…

#France2030 | 🧑🏻‍🔬 Hier, Françoise Slinger-Cecotti, sous-préfète de #Bellac, a posé la première pierre de l'Advanced Thorium Extraction Facility (#ATEF), à Bessines-sur-Gartempe, en présence d'Andréa Brouille, première vice-présidente de la région Nouvelle-Aquitaine, de Claude

#OranoMed reaches a significant milestone at #BessinesSurGartempe with the groundbreaking of ATEF, the first facility dedicated to the industrial-scale production of thorium-228, a precursor of lead-212. #RLT To learn more ➡️ oranomed.com/en/resources/n…

We have today expanded our strategic collaboration with Orano Med – it now includes the co-development of an additional six targeted alpha therapeutics candidates. 👉 investors.molecularpartners.com/news-releases/… #oncology #cancer #cancerresearch #immunooncology #partnership

🤝 Last week, we announced an expanded partnership with Molecular Partners, adding the development of six new targeted alpha therapeutic candidates to our pipeline - bringing the total to ten programs between the two companies. Read the Press Release: oranomed.com/en/resources/n…